Reflects the Intervention (AI Chatbot)

The goal of this clinical trial is to investigate the impact of an AI-powered chatbot intervention on improving knowledge, attitudes, and empowerment in breast cancer patients. The study focuses on female breast cancer patients, aged 18 years or older, who are receiving treatment at Kafr El-Sheikh University Hospital in Egypt. The main questions it aims to answer are: Can the AI chatbot intervention improve breast cancer knowledge compared to standard care? Can the AI chatbot intervention positively influence attitudes toward AI in healthcare? Does the AI chatbot intervention enhance patient empowerment in managing breast cancer? Researchers will compare: Intervention group (AI chatbot + standard care) to control group (standard care alone) to see if the AI chatbot intervention leads to greater improvements in knowledge, more positive attitudes towards AI, and higher perceived empowerment. Participants will: Engage with an AI-powered chatbot designed to provide personalized education on breast cancer, treatment options, and emotional support. Complete pre- and post-intervention assessments to measure changes in knowledge, attitudes toward AI, and empowerment. Receive standard care, including routine oncology consultations and nursing support, alongside the chatbot intervention (for the intervention group).

NCT Number	NCT06943911
Lead Sponsor	Mostafa Shaban
Conditions	Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment	122 participants
Start Date	2025-04-20
Primary Completion	2025-07-01 (estimated)
Study Completion	2025-07-15 (estimated)
Updated on ClinicalTrials.gov	2025-04-25